LGND:Ligand Pharmaceuticals Inc Snapshot | Charting | News | Options
$86.06 NASDAQ 4:00p ET
May 7 '24 		Ligand Reports First Quarter 2024 Financial Results BusinessWire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on LGND
    No News Available
    Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
    7:30a ET May 7 '24 BusinessWire
    Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
    8:31a ET April 23 '24 BusinessWire
    Ligand Pharmaceuticals Announces New Topiramate Injection Data Presen...
    8:15a ET April 8 '24 BusinessWire
    Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Ac...
    9:00a ET April 3 '24 BusinessWire
    Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Heal...
    4:01p ET March 5 '24 BusinessWire
    Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listi...
    8:00a ET March 4 '24 BusinessWire
    Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
    7:00a ET February 27 '24 BusinessWire
    Ligand Partner Eisai Receives Approval in Japan for Injection Formula...
    4:01p ET February 22 '24 BusinessWire

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.